Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest.
Novel controlled and targeted releasing hydrogen sulfide system exerts combinational cerebral and myocardial protection after cardiac arrest.
复制标题
新型可控靶向释放硫化氢系统在心脏骤停后发挥脑和心肌联合保护作用
DOI:
10.1186/s12951-021-00784-w
复制
发表时间:
2021-02-06
影响因子:
10.2
通讯作者:
Pang L
中科院分区:
文献类型:
--
作者:
Sun X;Wang Y;Wen S;Huang K;Huang J;Chu X;Wang F;Pang L
BackgroundCardiac arrest (CA) is a leading cause of death worldwide. Even after successful cardiopulmonary resuscitation (CPR), the majorities of survivals are companied with permanent myocardial and cerebral injury. Hydrogen sulfide (H2S) has been recognized as a novel gasotransmitter exerting multiple organ protection; however, the lacks of ideal H2S donors which can controlled release H2S to targeted organs such as heart and brain limits its application.ResultsThis work utilized mesoporous iron oxide nanoparticle (MION) as the carriers of diallyl trisulfide (DATS), with polyethylene glycol (PEG) and lactoferrin (LF) modified to MIONs to acquire the prolonged circulation time and brain-targeting effects, and a novel targeted H2S releasing system was constructed (DATS@MION-PEG-LF), which exhibited excellent biocompatibility, controlled-releasing H2S pattern, heart and brain targeting features, and the ability to be non-invasive traced by magnetic resonance imaging. DATS@MION-PEG-LF presented potent protective effects against cerebral and cardiac ischemic injury after CA in bothin vitrohypoxia/reoxygenation models andin vivoCA/CPR models, which mainly involves anti-apoptosis, anti-inflammatory and anti-oxidant mechanisms. Accordingly, the cardiac and cerebral functions were obviously improved after CA/CPR, with potentially improved survival.ConclusionsThe present work provides a unique platform for targeted controlled release of H2S based on MIONs, and offers a new method for combinational myocardial and cerebral protection from ischemic injury, bringing considerable benefits for CA patients.
登录
查看更多内容
影响因子:
37.8
作者:
Go AS;Mozaffarian D;Roger VL;Benjamin EJ;Berry JD;Blaha MJ;Dai S;Ford ES;Fox CS;Franco S;Fullerton HJ;Gillespie C;Hailpern SM;Heit JA;Howard VJ;Huffman MD;Judd SE;Kissela BM;Kittner SJ;Lackland DT;Lichtman JH;Lisabeth LD;Mackey RH;Magid DJ;Marcus GM;Marelli A;Matchar DB;McGuire DK;Mohler ER 3rd;Moy CS;Mussolino ME;Neumar RW;Nichol G;Pandey DK;Paynter NP;Reeves MJ;Sorlie PD;Stein J;Towfighi A;Turan TN;Virani SS;Wong ND;Woo D;Turner MB;American Heart Association Statistics Committee and Stroke Statistics Subcommittee
通讯作者:
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
影响因子:
4.7
作者:
Vandiver, M. Scott;Snyder, Solomon H.
通讯作者:
Snyder, Solomon H.
影响因子:
8
作者:
Katebi, Samira;Esmaeili, Abolghasem;Zarrabi, Ali
通讯作者:
Zarrabi, Ali
影响因子:
10.8
作者:
Paulis, Leonie E.;Geelen, Tessa;Strijkers, Gustav J.
通讯作者:
Strijkers, Gustav J.
影响因子:
6.3
作者:
Huang, Rongqin;Ke, Weilun;Pei, Yuanying
通讯作者:
Pei, Yuanying